Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review

Journal of Affective Disorders

Volumn 166, Issue , 2014, Pages 258-263

  Amerio, A ^a,b   Odone, A ^a,c   Marchesi, C ^a   Ghaemi, S N ^b,d  

^a UNIVERSITY OF PARMA   (Italy)

^b TUFTS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Comorbidity; Obsessive compulsive disorder; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOMIPRAMINE; CLOZAPINE; ESCITALOPRAM; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; NEUROLEPTIC AGENT;

BEHAVIOR THERAPY; BIPOLAR DISORDER; BRAIN DEPTH STIMULATION; DSM-III; DSM-IV; EUPHORIA; GRANDIOSE DELUSION; HUMAN; MANIA; MENTAL INSTABILITY; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOEDUCATION; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ADULT; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; MALE; OBSESSIVE-COMPULSIVE DISORDER; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84902288432     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.05.026     Document Type: Review

References (27)

1. B. Alevizos, C. Papageorgiou, and G.N. Christodoulou Obsessive-compulsive symptoms with olanzapine Int. J. Neuropsychopharmacol. 7 2004 375 377
2. A. Amerio, A. Odone, C.C. Liapis, and S.N. Ghaemi Diagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review Acta Psychiatr. Scand. 129 2014 343 358
3. A. Amerio, A. Odone, C. Marchesi, and S.N. Ghaemi Do antidepressant- induced manic episodes in obsessive-compulsive disorder patients represent the clinical expression of an underlying bipolarity? Aust. N. Z. J. Psychiatry, [Epub ahead of print], PubMed PMID: 24711576 2014
4. L. Baer, W.E. Minichiello, and M.A. Jenike Behavioral treatment in two cases of obsessive-compulsive disorder with concomitant bipolar affective disorder Am. J. Psychiatry 142 1985 358 360
5. L.W. Bisol, and D.R. Lara Improvement of obsessive-compulsive disorder with divalproex and lamotrigine in two patients with bipolar II disorder Pharmacopsychiatry 42 2009 37 39
6. C.H. Chang, S.Y. Chen, Y.L. Hsiao, S.J. Chen, S.T. Tsai, C.H. Chang, Y.Y. Yeh, and H.C. Tsai Hypomania-like syndrome induced by deep brain stimulation of bilateral anterior limbs of the internal capsules Prog. Neuro-Psychopharmacol. Biol. Psychiatry 33 2009 906 907
7. Y.W. Chen, and S.C. Dilsaver Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders Psychiatry Res. 59 1995 57 64
8. S.H. Downs, and N. Black The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions J. Epidemiol. Community Health 52 1998 377 384
9. M. Herstowska, and W.J. Cubala Escitalopram efficacy in obsessive-compulsive disorder comorbid with bipolar disorder Dusunen Adam 26 2013 115 116
10. G. Joshi, E. Mick, J. Wozniak, D. Geller, J. Park, S. Strauss, and J. Biederman Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder Bipolar Disord. 12 2010 196 204
11. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, and D. Moher The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration Br. J. Med. 339 2009 b2700
12. D. Marazziti, C. Pfanner, B. Dell'osso, A. Ciapparelli, S. Presta, G. Corretti, E. Di Nasso, F. Mungai, and L. Dell'osso Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study J. Psychopharmacol. 19 2005 392 394
13. G. Masi, S. Millepiedi, G. Perugi, C. Pfanner, S. Berloffa, C. Pari, and M. Mucci Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study CNS Drugs 23 2009 241 252
14. G. Masi, G. Perugi, S. Millepiedi, C. Toni, M. Mucci, C. Pfanner, S. Berloffa, C. Pari, and H.S. Akiskal Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications J. Child Adolesc. Psychopharmacol. 17 2007 475 486
15. S.B. Math, and Y.C. Janardhan Reddy Issues in the pharmacological treatment of obsessive-compulsive disorder Int. J. Clin. Pract. 61 2007 1188 1197
16. K.R. Merikangas, H.S. Akiskal, J. Angst, P.E. Greenberg, R.M. Hirschfeld, M. Petukhova, and R.C. Kessler Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch. Gen. Psychiatry 64 2007 543 552
17. B.A. Morel Traité des maladies mentales 1860 Masson, Paris
18. I. Pacchiarotti, D.J. Bond, R.J. Baldessarini, W.A. Nolen, H. Grunze, R.W. Licht, R.M. Post, M. Berk, G.M. Goodwin, G.S. Sachs, L. Tondo, R.L. Findling, E.A. Youngstrom, M. Tohen, J. Undurraga, A. Gonzalez-pinto, J.F. Goldberg, A. Yildiz, L.L. Altshuler, J.R. Calabrese, P.B. Mitchell, M.E. Thase, A. Koukopoulos, F. Colom, M.A. Frye, G.S. Malhi, K.N. Fountoulakis, G. Vazquez, R.H. Perlis, T.A. Ketter, F. Cassidy, H. Akiskal, J.M. Azorin, M. Valenti, D.H. Mazzei, B. Lafer, T. Kato, L. Mazzarini, A. Martinez-aran, G. Parker, D. Souery, A. Ozerdem, S.L. Mcelroy, P. Girardi, M. Bauer, L.N. Yatham, C.A. Zarate, A.A. Nierenberg, B. Birmaher, S. Kanba, R.S. El-mallakh, A. Serretti, Z. Rihmer, A.H. Young, G.D. Kotzalidis, G.M. Macqueen, C.L. Bowden, S.N. Ghaemi, C. Lopez-jaramillo, J. Rybakowski, K. Ha, G. Perugi, S. Kasper, J.D. Amsterdam, R.M. Hirschfeld, F. Kapczinski, and E. Vieta The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders Am. J. Psychiatry 170 2013 1249 1262
19. G. Perugi, C. Toni, F. Frare, M.C. Travierso, E. Hantouche, and H.S. Akiskal Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome J. Clin. Psychiatry 63 2002 1129 1134
20. P. Petrikis, C. Andreou, V.P. Bozikas, and A. Karavatos Effective use of olanzapine for obsessive-compulsive symptoms in a patient with bipolar disorder Can. J. Psychiatry 49 2004 572 573
21. C. Pfanner, D. Marazziti, L. Dell'osso, S. Presta, A. Gemignani, A. Milanfranchi, and G.B. Cassano Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study Int. Clin. Psychopharmacol. 15 2000 297 301
22. M. Raja, and A. Azzoni Clinical management of obsessive-compulsive- bipolar comorbidity: a case series Bipolar Disord. 6 2004 264 270
23. G. Remington, and M. Adams Risperidone and obsessive-compulsive symptoms J. Clin. Psychopharmacol. 14 1994 358 359
24. A. Schaffer, D. Mcintosh, B.I. Goldstein, N.A. Rector, R.S. Mcintyre, S. Beaulieu, R. Swinson, and L.N. Yatham The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders Ann. Clin. Psychiatry 24 2012 6 22
25. S. Stamouli, and L. Lykouras Quetiapine-induced obsessive-compulsive symptoms: a series of five cases J. Clin. Psychopharmacol. 26 2006 396 400
26. P. Stratta, S. De Cataldo, G. Mancini, D. Gianfelice, O. Rinaldi, and A. Rossi Quetiapine as adjunctive treatment of a case of rapid-cycling bipolar disorder with comorbidity Hum. Psychopharmacol. 18 2003 559 560
27. F. Uguz Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder Gen. Hosp. Psychiatry 32 2010 556 558